Concentra Group

S&P Global Ratings has raised Concentra’s long-term rating from BB- to BB, and also upgraded the rating on senior secured loans to BB+ and on unsecured bonds to B+. The upgrade was driven by strong operating results, adjusted leverage below 3.5x in the second quarter, and expected improvements to about 3.3x in 2026 and 3.0x in 2027; management’s net-leverage target is 2.5x. S&P praises higher adjusted EBITDA, strong operating cash flows and Concentra’s market-leading position in occupational health, but assigns a stable outlook and warns that persistently high leverage from aggressive M&A or distributions would pose a downgrade risk. » More on de.investing.com

Concentra has opened its first medical center in Boise, offering work-injury treatment, physical therapy, drug testing, DOT exams, pre-employment screenings and occupational health services. The facility complements telemedicine services via Concentra Telemed; a second location in Meridian is expected later this year. As of March 31, 2026, Concentra operated 632 occupational health centers and 411 onsite clinics, reported revenue growth of 15.46%, revenue of $2.23 billion and a market capitalization of $4 billion. » More on de.investing.com

Concentra reported revenue of $569.6 million for the first quarter of 2026 (up 13.7% year‑over‑year) and earnings per share of $0.40 (up 21%). The On‑Site Health Clinics segment grew 125%, adjusted EBITDA was $120.7 million, and free cash flow jumped to $9.9 million. The stock rose 4.53% in after‑hours trading; the company reaffirmed an optimistic outlook with projected EPS of $1.44 for 2026 and plans to expand with new de novo centers. » More on de.investing.com